lobbying_activities: 3336889

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3336889	758b374d-6b6a-4ac0-8c40-48cc912478af	Q1	HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION	40011087	HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION	2025	first_quarter	TAR	Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025. Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)		30000	0	0	2025-04-16T12:42:10-04:00